Jean-Luc Harousseau, Meletios A. Dimopoulos, Michael Wang, Alessandro Corso, Christine Chen, Michel Attal, Andrew Spencer, Zhinuan Yu, Marta Olesnyckyj, Jerome B. Zeldis, Robert D. Knight, Donna M. Weber. Better quality of response to lenalidomide plus dexamethasone is associated with improved clinical outcomes in patients with relapsed or refractory multiple myeloma. haematol [Internet]. 2010Oct.1 [cited 2022May18];95(10):1738-44. Available from: https://haematologica.org/article/view/5759